Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-14

Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating PS433540 for hypertension and that the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PS433540

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2011-09-14